Hodgkin's Risk Doubles In Women Who Smoke

Women who smoke are doubling their risk of developing Hodgkin's lymphoma and raising their risk of developing other blood-based cancers, say researchers out of Cancer Research UK, the largest cancer charity in the United Kingdom.

The findings, published in the British Journal of Cancer, are meant to influence a governmental decision about standardizing cigarette packaging in size, shape and color so as to limit the potential appeal of cigarette smoking to younger people.

Cancer Research UK director of tobacco control Jean King said,

"We urge the government to respond as quickly as possible to stop another generation from becoming addicted to a product that will kill half of all long-term smokers.”

Million Women study data used

Researchers reached their conclusions after drawing out data from the decade-long "Million Women" study. In addition to Hodgkin's lymphoma, the study found that women who smoke a pack a day were also at risk for leukemia, multiple myeloma and other blood disorders.

While in general the UK public is aware of the association between smoking and lung cancer as well as mouth and throat cancer, but a much smaller percentage of the public is aware of the growing association between smoking and cancers of the liver, pancreas, bowel, kidney, cervix, bladder, and lymphatic system.

Cigarette packaging addressed

For this reason, advocates at Cancer Research UK stress the need to downplay the packaging on cigarettes to discourage young people from starting the habit.

“These results highlight yet again how important smoking is as a cause of cancer," said study co-author Professor Valerie Beral. "Smoking raises the risk of many types of cancer, not just lung cancer, and also the risk of heart attack and stroke, which many people may not be aware of.”

Source: OnMedica

Photo by John Nyboer

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...